Literature DB >> 24076593

Interleukin-8 but not interleukin-6 variant may affect susceptibility to brucellosis.

Sadaf Asaei1, Manoochehr Rasouli, Ali Moravej.   

Abstract

BACKGROUND: Increased levels of interleukin-8 (IL-8) and interleukin-6 (IL-6) in acute human brucellosis have been reported. Previous studies have shown that the production and level of IL-6 and IL-8 cytokines are associated with the polymorphism of the encoding genes.
OBJECTIVE: To investigate the probable association between IL-6 (-174 C/G) and IL-8 (-251 A/T) gene polymorphisms and susceptibility/resistance to brucellosis.
METHODS: The patient group included 196 patients suffering from Brucella infection and the control group consisted of 82 healthy animal husbandmen from the same geographical area. IL-8 (-251 A/C) and IL-6 (-174 C/G) gene polymorphisms were analyzed by PCR-RFLP and Allele Specific PCR (AS-PCR) respectively.
RESULTS: The frequency of -251 IL-8 AA genotype was significantly lower in the controls compared with that of the patients (p=0.0051), while the frequencies of other genotypes (AT and TT) and alleles (A and T) were not significantly different among the participants. No association was found between IL-6 (-174 C/G) polymorphism and brucellosis.
CONCLUSION: This study indicates that the IL-8 -251 AA genotype may be considered as a genetic susceptibility factor for brucellosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24076593     DOI: IJIv10i3A4

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  2 in total

Review 1.  Retrospective and prospective perspectives on zoonotic brucellosis.

Authors:  Edgardo Moreno
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

2.  Association between the IL-10 and IL-6 polymorphisms and brucellosis susceptibility: a meta-analysis.

Authors:  Xiaochun Jin; Yueyuan Wu; Shuzhou Yin; Xu Chen; Youtao Zhang
Journal:  BMC Med Genet       Date:  2020-03-30       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.